SIS
FTXH icon

Sound Income Strategies’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Sound Income Strategies’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Hold
8,627
– – 0.01% 349
2026
Q1 		$298K Hold
8,627
– – 0.01% 327
2025
Q4 		$287K Buy
+8,627
New +$269K 0.01% 332

Other funds holding FTXH

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Sound Income Strategies's FTXH Position: Q2 2026 in Review

Sound Income Strategies held its First Trust Nasdaq Pharmaceuticals ETF (FTXH) position steady in Q2 2026 at 8,627 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #349.

Sound Income Strategies first reported a position in FTXH in Q4 2025 and has held it in 3 quarters since. 10 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

  • Sound Income Strategies held 8,627 shares of First Trust Nasdaq Pharmaceuticals ETF worth $329K as of Q2 2026.
  • Sound Income Strategies left its First Trust Nasdaq Pharmaceuticals ETF share count unchanged in Q2 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up 0.01% of Sound Income Strategies's portfolio in Q2 2026, its #349 holding.
  • Sound Income Strategies first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2025 and has held it in 3 quarters since.
  • 10 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.